Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in XGN — Exagen Inc.

CIK 1107261 HOUSTON, TX
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$139,509
-$122,697 QoQ
Shares Held
30,002
-65.7% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 57 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $12,609,280 across 6 Diagnostics & Research names. XGN ranks #6 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CSTL
Castle Biosciences Inc
 221,338 $5,278,911
2 ILMN
Illumina, Inc.
 26,700 $4,694,661
3 MEDP
Medpace Holdings, Inc.
 2,750 $1,456,372
4 BDSX
Biodesix Inc
 26,035 $587,089
5 IDXX
Idexx Laboratories Inc /De
 860 $452,738
6 XGN
Exagen Inc.
This page 		30,002 $139,509

All Filings in XGN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $139,509 30,002
2026-03-31 $262,206 87,402
2025-12-31 $469,376 77,200
2025-09-30 $305,522 27,800
2025-06-30 $194,044 27,800
2025-03-31 $90,468 25,200
2024-12-31 $84,870 20,700
2024-09-30 $67,362 21,800
2024-06-30 $39,676 21,800
2024-03-31 $64,872 40,800
2023-12-31 $81,192 40,800
2023-09-30 $98,736 40,800
2023-06-30 $137,170 47,300
2023-03-31 $114,939 47,300
2022-12-31 $113,520 47,300
2022-09-30 $128,183 47,300
2022-06-30 $271,502 47,300
2022-03-31 $602,250 75,000
2021-12-31 $1,011,810 87,000
2021-09-30 $1,183,200 87,000
2021-06-30 $1,161,725 77,500
2021-03-31 $1,312,500 75,000
2020-12-31 $966,240 73,200
2020-09-30 $793,488 73,200